Company Profile

当前位置: > Company > Company Profile

Company Profile

    Asieris Pharmaceuticals, founded in March 2010 in China Medical City in Jiangsu Taizhou, is the only China-based, globally oriented company specializing in the R&D of new drugs for the treatment of genitourinary tumors and related diseases. 

    Our professional teams are located in Shanghai, Beijing, and Taizhou (Jiangsu), as well as in the United States, with departments responsible for domestic and international clinical development, regulatory affairs, pharmaceutical sciences, new drug discovery, and business development. 

    With focus on genitourinary tumors and related diseases, our goal is to establish a leading position in this field with our own unique strategies. Through the “twin engines” of proprietary R&D and in-licensing, we explore the global values of proprietary first-in-class new drugs of breakthrough potential. Meanwhile, we in-license late stage or marketed new drugs from overseas for the Chinese market to enhance our product pipeline and allow us to quickly establish our leadership position in the domestic market.